OIG And CMS Agree Medicaid Needs National Drug Price Benchmark Based On Acquisition Cost
This article was originally published in The Pink Sheet Daily
Executive Summary
With First DataBank scheduled to end publishing average wholesale price data in September, there is an opportunity for states to switch to pharmacy reimbursement based on actual acquisition costs.